By Tony Fong

NEW YORK (GenomeWeb News) – AutoGenomics is still biding its time to proceed with an initial public offering, two years after filing its preliminary prospectus for the IPO.

The company last month amended its S-1 filing with the US Securities and Exchange Commission, suggesting that it might move on its plans to go public.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.